Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002932047 | SCV003256777 | likely benign | Type A2 brachydactyly; Acromesomelic dysplasia 3 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004603252 | SCV005095285 | uncertain significance | Inborn genetic diseases | 2024-05-07 | criteria provided, single submitter | clinical testing | The c.1394A>G (p.Q465R) alteration is located in exon 13 (coding exon 10) of the BMPR1B gene. This alteration results from a A to G substitution at nucleotide position 1394, causing the glutamine (Q) at amino acid position 465 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |